Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $66.85 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $23.14 | 1 | $0 (2017) |
| LEICA MICROSYSTEMS INC. | $18.82 | 1 | $0 (2023) |
| BARD PERIPHERAL VASCULAR, INC. | $12.98 | 1 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $11.91 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.82 | 1 | LEICA MICROSYSTEMS INC. ($18.82) |
| 2019 | $12.98 | 1 | BARD PERIPHERAL VASCULAR, INC. ($12.98) |
| 2018 | $11.91 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($11.91) |
| 2017 | $23.14 | 1 | Medtronic USA, Inc. ($23.14) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/01/2023 | LEICA MICROSYSTEMS INC. | HydroMARK Breast Biopsy Site Marker (Device) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Devices | ||||||
| 11/04/2019 | BARD PERIPHERAL VASCULAR, INC. | — | Food and Beverage | In-kind items and services | $12.98 | General |
| 05/31/2018 | Bayer HealthCare Pharmaceuticals Inc. | Gadavist (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Radiology | ||||||
| 09/28/2017 | Medtronic USA, Inc. | PlasmaBlade (Device) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Advanced Energy Cutting Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,486 | 2,522 | $201,391 | $81,260 |
| 2022 | 12 | 2,754 | 2,805 | $225,072 | $94,014 |
| 2021 | 9 | 2,178 | 2,190 | $181,235 | $94,549 |
| 2020 | 9 | 1,047 | 1,049 | $154,109 | $120,650 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 763 | 764 | $60,356 | $27,147 | 45.0% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 738 | 739 | $47,296 | $20,899 | 44.2% |
| 77067 | Screening mammography | Office | 2023 | 159 | 159 | $12,561 | $5,741 | 45.7% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 223 | 234 | $15,210 | $5,086 | 33.4% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 155 | 171 | $14,364 | $4,920 | 34.3% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 150 | 150 | $9,600 | $4,318 | 45.0% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 98 | 100 | $10,400 | $3,463 | 33.3% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 132 | 137 | $11,470 | $3,445 | 30.0% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2023 | 22 | 22 | $8,140 | $2,536 | 31.2% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Facility | 2023 | 14 | 14 | $5,530 | $1,802 | 32.6% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 16 | 16 | $3,936 | $1,285 | 32.7% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2023 | 16 | 16 | $2,528 | $617.25 | 24.4% |
| 77067 | Screening mammography | Facility | 2022 | 953 | 953 | $75,287 | $35,008 | 46.5% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 956 | 956 | $61,184 | $28,242 | 46.2% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2022 | 271 | 287 | $18,655 | $6,663 | 35.7% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2022 | 185 | 210 | $17,640 | $6,408 | 36.3% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2022 | 122 | 122 | $12,688 | $4,482 | 35.3% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2022 | 156 | 163 | $13,468 | $4,425 | 32.9% |
| 19083 | Biopsy of breast and placement of locating device using ultrasound, first growth | Facility | 2022 | 21 | 22 | $8,140 | $2,746 | 33.7% |
| 77049 | Mri scan of both breasts | Facility | 2022 | 27 | 27 | $6,642 | $2,424 | 36.5% |
| 19081 | Biopsy of breast and placement of locating device using x-ray with needle, first growth | Facility | 2022 | 13 | 14 | $5,530 | $1,866 | 33.8% |
| 19285 | Placement of locating device in breast using ultrasound guidance, first growth | Facility | 2022 | 12 | 12 | $2,268 | $836.73 | 36.9% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2022 | 15 | 15 | $2,370 | $626.32 | 26.4% |
| 76098 | X-ray of surgical specimen | Facility | 2022 | 23 | 24 | $1,200 | $285.82 | 23.8% |
| 77067 | Screening mammography of both breasts | Facility | 2021 | 773 | 773 | $61,067 | $30,333 | 49.7% |
About Dr. Stacey Vitiello, MD
Dr. Stacey Vitiello, MD is a Diagnostic Radiology healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245203611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Vitiello, MD has received a total of $66.85 in payments from pharmaceutical and medical device companies, with $18.82 received in 2023. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($66.85).
As a Medicare-enrolled provider, Vitiello has provided services to 8,465 Medicare beneficiaries, totaling 8,566 services with total Medicare billing of $390,472. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Staten Island, NY
- Active Since 02/08/2006
- Last Updated 01/14/2008
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1245203611
Products in Payments
- PlasmaBlade (Device) $23.14
- HydroMARK Breast Biopsy Site Marker (Device) $18.82
- Gadavist (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Staten Island
Rita Bukhman
Diagnostic Radiology — Payments: $23,210
Dr. Ayub Suleiman, M.d, M.D
Diagnostic Radiology — Payments: $13,399
Dr. Nathan Cornish, D.o, D.O
Diagnostic Radiology — Payments: $3,145
Rehan Ali, Md, MD
Diagnostic Radiology — Payments: $2,430
Dr. Arton Isa, Md, MD
Diagnostic Radiology — Payments: $809.18
Dr. Mark Raden, M.d, M.D
Diagnostic Radiology — Payments: $753.01